Mercer Global Advisors
LAB icon

Mercer Global Advisors’s Standard BioTools LAB Stock Holding History

Mercer Global Advisors’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.7K Buy
62,777
+11,790
+23% +$14.3K ﹤0.01% 3111
2025
Q4 		$65.3K Buy
+50,987
New +$68.5K ﹤0.01% 2768
2021
Q2 		– Sell
-25,000
Closed -$113K – 1706
2021
Q1 		$113K Buy
+25,000
New +$137K ﹤0.01% 1547

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Mercer Global Advisors's LAB Position: Q1 2026 in Review

Mercer Global Advisors increased its Standard BioTools (LAB) stake by 23% in Q1 2026, buying an estimated $14.3K and bringing the position to 62,777 shares worth $57.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3111.

Mercer Global Advisors first reported a position in LAB in Q1 2021 and has held it in 3 quarters since. The position peaked at $113K in Q1 2021. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Mercer Global Advisors held 62,777 shares of Standard BioTools worth $57.7K as of Q1 2026.
  • Mercer Global Advisors bought 11,790 Standard BioTools shares in Q1 2026, an estimated $14.3K.
  • Standard BioTools made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #3111 holding.
  • Mercer Global Advisors first reported a position in Standard BioTools in Q1 2021 and has held it in 3 quarters since.
  • Mercer Global Advisors's Standard BioTools position peaked at $113K in Q1 2021.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.